# Immunovant, Inc.: Form 8-K, filed Apr 21, 2025

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2025-04-21
- Accepted by EDGAR: Apr 21, 2025, 07:18 ET
- Period: 2025-04-18
- Accession: 0001764013-25-000078
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000078/imvt-20250418.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000078/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401325000078/imvt-20250418.htm

Filed Apr 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001764013-25-000078. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
